VAERS reports by lot

GSK Varicella/Shingles lot A4D72: VAERS reports

51 VAERS reports list lot A4D72 as a GSK Varicella/Shingles vaccine, received between 2019-01-10 and 2023-05-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
51
Reports
2%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5630%
Injection-site / Local reaction4022%
Musculoskeletal2212%
Neurological179%
Dermatological (non-injection-site)179%
Cardiac / Cardiovascular84%
Respiratory84%
Allergic / Anaphylactic74%
Gastrointestinal74%
Psychiatric / Neuropsychiatric32%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California12
Pennsylvania4
North Carolina4
Wisconsin4
Texas4
Georgia3
Oregon2
Louisiana2
New Mexico2
Illinois2
Colorado1
Washington1

Reports by month received

2019-0123
2019-0210
2019-035
2019-041
2019-052
2019-063
2019-071
2019-091
2019-112
2020-081
2022-031
2023-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.